Home › Papillary Thyroid Cancer
Papillary Thyroid Cancer clinical trials recruiting in the U.S.
7 studies for Papillary Thyroid Cancer are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Studies on Tumors of the Thyroid
RecruitingObservational study
6 Months – 98 Years · All sexes · Updated Oct 2, 2026 · NCT00001160Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07140757Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors
Recruiting
Ages 18 and older · All sexes · Updated Jul 8, 2026 · NCT07545837XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT06959641Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 2, 2026 · NCT06440850Targeted Therapy to Increase RAI Uptake in Metastatic DTC
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT05024929Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Dec 12, 2024 · NCT05668962From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.